FDA approves Emergent vaccine for mpox as company plans to donate 50,000 doses

Emergent BioSolutions scored an expanded FDA approval for its single-dose vaccine, ACAM2000, to now include the prevention of mpox disease in people at high risk …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Are We Testing Enough for H5N1?

With H5N1 avian influenza causing unprecedented outbreaks in mammals around the world — including U.S. dairy cattle — infectious disease experts are raising concerns that

April 26, 2024

Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound

Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are once again enveloping the Pharmalot

December 12, 2023

As midwife-assisted home births rise, so too do high-risk births outside hospitals

Kay Kay Lineweaver’s first birthing experience in 2021 didn’t go as planned. Her baby was breech and the doctor wouldn’t allow her to try to

February 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.